Sign Up to like & get
recommendations!
0
Published in 2021 at "NeuroImage"
DOI: 10.1016/j.neuroimage.2021.117953
Abstract: Optimal pharmacokinetic models for quantifying amyloid beta (Aβ) burden using both [18F]flutemetamol and [18F]florbetaben scans have previously been identified at a region of interest (ROI) level. The purpose of this study was to determine optimal…
read more here.
Keywords:
time window;
18f florbetaben;
18f flutemetamol;
flutemetamol 18f ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "BMC Neuroscience"
DOI: 10.1186/s12868-018-0447-7
Abstract: BackgroundAlthough amyloid beta (Aβ) imaging is widely used for diagnosing and monitoring Alzheimer’s disease in clinical fields, paralleling comparison between 18F-flutemetamol and 18F-florbetaben was rarely attempted in AD mouse model. We performed a comparison of…
read more here.
Keywords:
18f flutemetamol;
flutemetamol 18f;
flutemetamol images;
18f florbetaben ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "EJNMMI Research"
DOI: 10.1186/s13550-018-0425-1
Abstract: BackgroundFlorbetaben, a 18F-labeled stilbene derivative (Neuraceq®, formerly known as BAY-949172), is a diagnostic radiopharmaceutical developed to visualize β-amyloid plaques in the brain. Here, we report a pilot study evaluating patients with suspected cardiac amyloidosis for…
read more here.
Keywords:
two patients;
18f florbetaben;
amyloid deposition;
whole body ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Psychiatry Investigation"
DOI: 10.4306/pi.2017.14.6.883
Abstract: Objective Recently developed 18F-labelled amyloid beta (Aβ) positron emission tomography (PET) tracers have demonstrated potentials to enable more prevalent application of amyloid imaging in the clinical setting. The aim of this study is to demonstrate…
read more here.
Keywords:
analysis;
cerebral retention;
18f florbetaben;
voxel ... See more keywords